Clinical Efficacy of Pivmecillinam (Selexid(R)) in Lower Urinary Tract Infections.
- Author:
Yong Woo LEE
1
;
Sae Kook CHANG
Author Information
1. Department of Urology, Kyungpook National University, School of Medicine Taegu, Korea.
- Publication Type:Original Article
- Keywords:
antibiotics;
Pivmecillinam;
Selexid;
urinary tract infection
- MeSH:
Amdinocillin Pivoxil*;
Anti-Bacterial Agents;
Cystitis;
Diarrhea;
Enterococcus;
Gyeongsangbuk-do;
Humans;
Pseudomonas Infections;
Serratia;
Serratia Infections;
Staphylococcus;
Urethritis;
Urinary Tract Infections*;
Urinary Tract*
- From:Korean Journal of Urology
1983;24(3):413-417
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Effect of pivmecillinam hydrochloride was evaluated on 20 patients with cystitis and 13 patients with urethritis seen in urologic department of Kyungpook National University Hospital during past 4 months periods from April 1982 through August 1982. Pivmecillinam was given orally at a dose of 600mg (3 tablets) tid for 4 days (total 12 tablets) and following results were obtained. 1. In cystitis, effective result was observed in 19 out of 20 patients, giving therapeutic rate of 95%, and pivmecillinam was effective against all G (-) bacilli infections including E. coli except pseudomonas infection in 1. 2. In urethritis, effective result was noticed in 9 out of 13 patients, giving therapeutic rate of 70%, and pivmecillinam was effective against staphylococcus infection in 6 out of 7 patients, serratia infection in 1 out of 2 and G (-), bacilli infection in 1. However, it was ineffective against staphylococcus, serratia, enterococcus and unknown organism in 1 case, respectively. 3. As to the side effect, only diarrhea was observed in one of total 33 patients.
